EUVIMEDEUVIMED entdecken
Crossref

Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants

Camino Trobajo-Sanmartín iD, Ana Miqueleiz, Marcela Guevara, Miguel Fernández-Huerta, Cristina Burgui, Itziar Casado, Fernando Baigorria, Ana Navascués, Carmen Ezpeleta, Jesús Castilla

The Journal of Infectious Diseases · 01.02.2023 · 227 (3) · 332-338

DOI: 10.1093/infdis/jiac385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 20.09.2022. Verfasst von Camino Trobajo-Sanmartín und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Salud Pblica de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Horizon 2020 program of the European Commission, Carlos III Institute of Health with the European Regional Development, Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We compare the risk of coronavirus disease 2019 (COVID-19) outcomes among co-circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants between January 2021 and May 2022 in Navarra, Spain.

Methods

We compared the frequency of hospitalization and severe disease (intensive care unit admission or death) due to COVID-19 among the co-circulating variants. Variants analyzed were non–variants of concern (non-VOCs), Alpha, Delta, Omicron BA.1, and Omicron BA.2. Logistic regression models were used to estimate adjusted odds ratio (aOR).

Results

The Alpha variant had a higher risk of hospitalization (aOR, 1.86 [95% confidence interval {CI}, 1.28–2.71]) and severe disease (aOR, 2.40 [95% CI, 1.31–4.40]) than non-VOCs. The Delta variant did not show a significantly different risk of hospitalization (aOR, 0.73 [95% CI, .40–1.30]) and severe disease (aOR, 3.04 [95% CI, .57–16.22]) compared to the Alpha variant. The Omicron BA.1 significantly reduced both risks relative to the Delta variant (aORs, 0.28 [95% CI, .16–.47] and 0.23 [95% CI, .12–.46], respectively). The Omicron BA.2 reduced the risk of hospitalization compared to BA.1 (aOR, 0.52 [95% CI, .29–.95]).

Conclusions

The Alpha and Delta variants showed an increased risk of hospitalization and severe disease, which decreased considerably with the Omicron BA.1 and BA.2. Surveillance of variants can lead to important differences in severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansHospitalizationIntensive Care Units

Stichwörter der Autor:innen

Alpha variantCOVID-19Delta variantOmicron variantSARS-CoV-2 variantshospitalizationsevere diseasevariant of concern

Autor:innen und Institutionen

  • Instituto de Salud Pblica de Navarra, Pamplona, Spain.
  • CIBER Epidemiologa y Salud Pblica, Madrid, Spain.
  • Navarra Institute for Health Research, Pamplona, Spain.
  • Clinical Microbiology Department, Hospital Universitario de Navarra, Pamplona, Spain.

ORCID-Profile: Camino Trobajo-Sanmartín

Förderung

  • Horizon 2020 program of the European Commission
  • Carlos III Institute of Health with the European Regional Development
  • Fund

Zitieren

APA

Trobajo-Sanmartín, C., Miqueleiz, A., Guevara, M., Fernández-Huerta, M., Burgui, C., Casado, I., Baigorria, F., Navascués, A., Ezpeleta, C., & Castilla, J. (2023). Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants. The Journal of Infectious Diseases, 227(3), 332-338. https://doi.org/10.1093/infdis/jiac385

Vancouver

Trobajo-Sanmartín C, Miqueleiz A, Guevara M, Fernández-Huerta M, Burgui C, Casado I, et al. Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants. The Journal of Infectious Diseases. 2023;227(3):332-338. doi:10.1093/infdis/jiac385

BibTeX
@article{TrobajoSanmartn2023,
  author = {Trobajo-Sanmartín, Camino and Miqueleiz, Ana and Guevara, Marcela and Fernández-Huerta, Miguel and Burgui, Cristina and Casado, Itziar and Baigorria, Fernando and Navascués, Ana and Ezpeleta, Carmen and Castilla, Jesús},
  title = {Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  volume = {227},
  number = {3},
  pages = {332--338},
  doi = {10.1093/infdis/jiac385}
}
Kostenlos starten →